Our expertise in biology, automation, bioinformatics and in silico analysis helps cell & gene therapy pioneers advance the discovery phase of their clinical candidates.
From early discovery onwards, OXGENE’s team of expert scientists can help advance your pre-clinical pipeline. We can deploy our proprietary SLIM™ display discovery platform to find scFvs to bind your target antigen for CAR-T cell therapies, screen for novel AAV capsids with improved infectivity and specificity, or identify tissue specific promoters to enhance transgene expression in AAV or lentiviral vectors. We can then support you through process development and scale up, in preparation for GMP manufacture.
Download the resource to continue reading.